Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.68 is 18% above its 5-year average of 3.97, near the high end of its 5-year range (2.75–5.36).
As of the fiscal period ended Tuesday, June 30, 2026. 36.40% above its 12-month average of 3.43.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.68.
QUICK RATIO (ACID-TEST)
4.68
QUICK RATIO (ACID-TEST) AVG TTM
3.43
QUICK RATIO (ACID-TEST) AVG 3Y
3.70
QUICK RATIO (ACID-TEST) AVG 5Y
3.97
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+36.40%
CURRENT VS 3Y AVG
+26.38%
CURRENT VS 5Y AVG
+17.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.79
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
+67.87%
vs the sector median at left
Adaptive Biotechnologies Corporation
Market Cap
$4.78B
Quick Ratio (Acid-Test)
4.68
TTM Avg
3.43
3Y Avg
3.70
5Y Avg
3.97
Market Cap
$4.81B
Quick Ratio (Acid-Test)
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.92B
Quick Ratio (Acid-Test)
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
Market Cap
$5.02B
Quick Ratio (Acid-Test)
11.31
TTM Avg
9.52
3Y Avg
6.89
5Y Avg
6.89
Market Cap
$4.50B
Quick Ratio (Acid-Test)
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
Market Cap
$5.20B
Quick Ratio (Acid-Test)
7.02
TTM Avg
8.28
3Y Avg
8.59
5Y Avg
7.77
Market Cap
$5.20B
Quick Ratio (Acid-Test)
2.79
TTM Avg
2.90
3Y Avg
2.74
5Y Avg
2.21
Market Cap
$4.34B
Quick Ratio (Acid-Test)
16.24
TTM Avg
19.89
3Y Avg
20.20
5Y Avg
22.94
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corporation (ADPT) | $4.78B | 4.68 | 3.43 | 3.70 | 3.97 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | 6.95 | 6.77 | 6.23 | 10.87 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.92B | 26.10 | 14.27 | 14.23 | 14.47 |
| BillionToOne, Inc. (BLLN)vs › | $5.02B | 11.31 | 9.52 | 6.89 | 6.89 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.50B | 5.08 | 3.83 | 4.06 | 4.06 |
| Erasca, Inc. (ERAS)vs › | $5.11B | 8.29 | 9.94 | 10.32 | 11.01 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | 7.02 | 8.28 | 8.59 | 7.77 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 2.79 | 2.90 | 2.74 | 2.21 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.34B | 16.24 | 19.89 | 20.20 | 22.94 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.27B | 13.57 | 9.78 | 9.13 | 11.38 |
Quick Ratio
4.68
Excludes inventory
Current Ratio
4.79
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 4.68 |
| 2026-03-31 | 3.22 |
| 2025-12-31 | 3.23 |
| 2025-09-30 | 3.26 |
| 2025-06-30 | 2.75 |
| 2025-03-31 | 2.82 |
| 2024-12-31 | 2.81 |
| 2024-09-30 | 3.38 |
| 2024-06-30 | 3.84 |
| 2024-03-31 | 4.35 |
| 2023-12-31 | 4.50 |
| 2023-09-30 | 4.46 |
| 2023-06-30 | 4.80 |
| 2023-03-31 | 5.34 |
| 2022-12-31 | 4.99 |
| 2022-09-30 | 5.26 |
| 2022-06-30 | 3.77 |
| 2022-03-31 | 3.46 |
| 2021-12-31 | 3.37 |
| 2021-09-30 | 3.67 |
| 2021-06-30 | 5.36 |
| 2021-03-31 | 7.00 |
| 2020-12-31 | 6.78 |
| 2020-09-30 | 8.59 |
| 2020-06-30 | 6.30 |
| 2020-03-31 | 7.37 |
| 2019-12-31 | 7.71 |
| 2019-09-30 | 8.08 |
| 2019-06-30 | 5.80 |
| 2019-03-31 | 7.13 |
| 2018-12-31 | 7.58 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
